Biodegradable Stent Copolymer Coating Surface Erosion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing endoprostheses, such as stents, often remain permanently in the body after implantation, failing to erode over time, which can hinder the natural recovery of occluded or weakened passageways, and lack effective drug delivery mechanisms for conditions like restenosis.

Innovation Solution

A biodegradable stent coated with a copolymer that exhibits surface erosion, combining elastic and rigid segments with therapeutic agents, allowing for controlled drug release and maintaining mechanical integrity for an extended period before eroding, thereby facilitating tissue compatibility and recovery.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If a permanent endoprosthesis is used to maintain mechanical support, then structural stability is improved, but tissue recovery is hindered due to permanent foreign material presence

Engineering Contradiction:
Improvemechanical supportVSAvoidhindrance to tissue recovery
Core Design Contradiction:
StrengthVSObject-generated harmful factors

Solution Approach 1:

The endoprosthesis is designed as a temporary, biodegradable device that provides mechanical support during the critical healing period and then degrades completely. The stent is made from erodible materials such as polylactic acid or magnesium alloys, which gradually break down into biocompatible byproducts that are naturally eliminated from the body, allowing permanent replacement of the natural passageway structure without permanent foreign material interference

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The mechanical properties of the endoprosthesis are dynamically adjusted through controlled degradation. The material composition and structural parameters are designed to maintain high strength during the initial implantation and healing phase, then progressively reduce mechanical support as tissue recovery progresses, ultimately transitioning from a load-bearing device to complete biodegradation

Inventive Principle:
Principle #35Parameter changes

2Reliability

If drug delivery mechanisms are added to treat conditions like restenosis, then therapeutic effectiveness is improved, but device complexity increases

Engineering Contradiction:
Improvetherapeutic effectivenessVSAvoiddevice complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The drug delivery function is merged with the structural stent body and coating layers. Therapeutic agents are incorporated directly into the polymer matrix or coating formulation, allowing simultaneous structural support and controlled drug release from the same device components, thereby treating restenosis and other vascular conditions without adding separate complex delivery systems

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The endoprosthesis is designed as a multi-functional device that combines mechanical support, controlled drug delivery, and biodegradation capabilities in a single integrated structure. The coating layers serve multiple purposes including drug reservoir, controlled release mechanism, and surface modification for thrombosis resistance, eliminating the need for separate specialized components

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The biodegradable stent ensures controlled drug delivery and mechanical stability for up to 30 days or more, allowing for effective treatment and eventual natural recovery of the passageway without leaving permanent foreign material.

Implementation Method 1

The copolymer can include rigid segments and flexible segments, and the rigid segments can have an elastic modulus of about 200 MPa or more. The rigid segments can exhibit hydrolytic degradation by bulk erosion.

Methodology Applied
Scientific EffectHydrolytic degradation: Hydrolysis

Implementation Method 2

The flexible segments can be relatively resistant to hydrolytic degradation and can be susceptible to enzymatic surface degradation. The degradation enzyme can include lipases.

Methodology Applied
Scientific EffectEnzymatic degradation: Enzyme

Data Source

PatentUS9314551B2Block copolymer-coated endoprosthesis
Publication Date: 2016.04.19 BOSTON SCIENTIFIC SCIMED INC
  • US9314551B2 patent drawing
  • US9314551B2 patent drawing
  • US9314551B2 patent drawing

AI summary

In embodiments, a stent includes a copolymer having a modulus of about 10 MPa or less and exhibiting hydrolytic degradation substantially by surface erosion. For example, the copolymer can include elastic segments formed of trimethyl carbonate polymer or copolymer, and rigid segments formed of a lactide, glycolide, ε-caprolactone polymer or copolymer.